Vas Narasimhan | Chief Executive Officer |
Samir Shah | Global Head of Investor Relations |
Harry Kirsch | Chief Financial Officer |
Marie France | President of Novartis Pharmaceuticals |
Susanne Schaffert | President of Novartis Oncology |
John Tsai | Head of Global Drug Development and Chief Medical Officer |
Richard Saynor | Chief Executive Officer |
Karen Hale | Chief Legal Officer |
Graham Parry | Bank of America |
Peter Welford | Jefferies |
Andrew Baum | Citi |
Laura Sutcliffe | UBS |
Simon Baker | Redburn |
Keyur Parekh | Goldman Sachs |
Seamus Fernandez | Guggenheim Security |
Sureta Capilla (Ph) | Morgan Stanley |
Jo Walton | Credit Suisse |
Richard Buffett | JP Morgan |
Richard Parkes | Exane BNP Paribas |
Naresh Chouhan | Intron Health |
Florent Cespedes | SocGen |
Richard Wagner | Wolfe Research |
Wimal Kapadia | Bernstein |
Emmanuel Papadakis | Deutsche Bank |
Stefan Schneider | Global |
Good morning and good afternoon, and welcome to the Novartis Q3, 2021 results release, conference call, and live webcast. Please note that during the presentation, all participants will be in a listen-only mode, and the conference is being recorded. After the presentation, there will be an opportunity to ask questions by [Operator Instructions] at anytime during the conference. A recording of the conference call, including the Q&A session will be available on our website shortly after the call ends. Should anyone need assistance joining the conference call, they may signal the Operator by [Operator Instruction].